Figure 1

Loss of immunostaining in adenomas from HNPCC-patients with disease-causing mutations. Top: Loss of MLH1 and PMS2 staining in adenoma L2C from a patient with a nonsense mutation in MLH1. Bottom: Loss of MSH2 and MSH6 immunostaining in adenoma S1E from a patient with a frameshift mutation in MSH2.